Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

Registry data suggest that disease progression in pulmonary arterial hypertension (PAH) is indicative of poor prognosis. However, the prognostic relevance of PAH-related morbidity has not been formally evaluated in randomized controlled trials. The purpose of these analyses was to assess the impact...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2018-02, Vol.71 (7), p.752-763
Hauptverfasser:	McLaughlin, Vallerie V., Hoeper, Marius M., Channick, Richard N., Chin, Kelly M., Delcroix, Marion, Gaine, Sean, Ghofrani, Hossein-Ardeschir, Jansa, Pavel, Lang, Irene M., Mehta, Sanjay, Pulido, Tomás, Sastry, B.K.S., Simonneau, Gérald, Sitbon, Olivier, Souza, Rogério, Torbicki, Adam, Tapson, Victor F., Perchenet, Loïc, Preiss, Ralph, Verweij, Pierre, Rubin, Lewis J., Galiè, Nazzareno
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Clinical trials Confidence intervals disease progression GRIPHON Heart Hospitalization Human health and pathology Hypertension Intubation landmark analysis Life Sciences Lung diseases Medical prognosis Morbidity Mortality Patients Pulmonary hypertension Pulmonology and respiratory tract Risk assessment Sensitivity analysis SERAPHIN Studies Substance abuse treatment survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!